ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MCK McKesson Corporation

464.65
-5.91 (-1.26%)
Dec 01 2023 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 809,544
Bid Price
Ask Price
News -
Day High 476.3493

Low
331.75

52 Week Range

High
476.3493

Day Low 464.32
Share Name Share Symbol Market Stock Type
McKesson Corporation MCK NYSE Common Stock
  Price Change Price Change % Share Price Last Trade
-5.91 -1.26% 464.65 18:06:12
Open Price Low Price High Price Close Price Previous Close
470.55 464.32 476.3493 464.65 470.56
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
27,602 809,544 US$ 470.82 US$ 381,151,554 - 331.75 - 476.3493
Last Trade Type Quantity Price Currency
18:12:38 formt 125 US$ 464.65 USD

McKesson (MCK) Options Flow Summary

Overall Flow

Bullish

Net Premium

40k

Calls / Puts

200.00%

Buys / Sells

200.00%

OTM / ITM

50.00%

Sweeps Ratio

0.00%

McKesson Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
61.83B 133.06M - 276.72B 3.56B 26.75 17.37
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

McKesson News

Date Time Source News Article
11/13/202313:54Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
11/09/202315:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/07/202315:03Edgar (US Regulatory)Form 8-K - Current report
11/07/202311:16Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
11/06/202308:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/03/202312:28Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
11/01/202315:10Business WireMcKesson Corporation Reports Fiscal 2024 Second Quarter..
11/01/202315:05Edgar (US Regulatory)Form 8-K - Current report
10/26/202307:00Business WireMcKesson Corporation Declares Quarterly Dividend
10/18/202308:03IH Market NewsWednesday’s Wall Street Highlights: ASML, Nvidia, United..
10/16/202307:54Finscreener.orgMCK Stock: is This S&P 500 Company a Buy, Sell, or Hold?
10/16/202306:02Edgar (US Regulatory)Form 8-K - Current report
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No MCK Message Board. Create One! See More Posts on MCK Message Board See More Message Board Posts

Historical MCK Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week457.92476.3493453.79465.08927,7786.731.47%
1 Month447.94476.3493438.81458.15855,63116.713.73%
3 Months418.36476.3493417.65449.40771,38446.2911.06%
6 Months392.30476.3493383.82430.27771,64672.3518.44%
1 Year381.70476.3493331.75395.17891,33782.9521.73%
3 Years183.06476.3493169.09297.98997,378281.59153.82%
5 Years123.03476.3493106.11210.551,341,780341.62277.67%

McKesson Description

McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com